Cutting-edge technology has allowed scientists to examine young and old brains with single-cell resolution, gaining insights into how we can rejuvenate our brain cells to stay sharp. 


Stanford University scientist and corresponding author on the new study, Dr. Anne Brunet (image: labxchange.org). 

Brain &amp; Neurons

Four FDA-Approved Drugs that Reduce Chances of Aging-Related Death

Dr. Nir Barzilai, the director of aging research at Albert Einstein College of Medicine, discusses the science behind SGLT2 inhibitors, metformin, bisphosphonates, and GLP-1 agonists.

Dr. Nir Barzilai, the director of aging research at Albert Einstein College of Medicine, relays that we have four FDA-approved drugs that lower human mortality: SGLT2 inhibitors, bisphosphonates, metformin, and GLP-1 agonists.

Aging &amp; Longevity

Wegovy is now FDA-approved to lower the risk of mortality from heart disease, but not everyone may benefit. 


Popular weight loss drug reduces risk of death from heart disease. 

Cardiovascular

Based on human evidence, Harvard and MIT scientists determine the most promising anti-aging interventions, including NAD+ precursors, spermidine, and senolytics. 


MIT’s Leonard Guarente, Ph.D. (image: amacad.org), Harvard’s David Sinclair, Ph.D. (image: buckinstitute.org), and University of Paris Descartes’ Guido Kromer, Ph.D., M.D. (image: createcures.org). 

David Sinclair and fellow top aging biology researchers review clinical trials pertaining to the eight anti-aging compounds. 

Search Result: GLP-1 agonists

Brain Aging Interventions: Key Insights from a New Stanford Study

Four FDA-Approved Drugs that Reduce Chances of Aging-Related Death

FDA Approves Drug Similar to Ozempic for Reducing Heart Disease Risks: The New Antidote to Aging?

David Sinclair and Colleagues Summarize 8 Anti-Aging Medicines Applicable to Humans